Showing results (41-50 of 52) with videos related to
Sort By:
Pageof 6
Bioorganic & Medicinal Chemistry Letters|November 18, 2004
Development of an efficient and selective radioligand for bradykinin B1 receptor occupancy studiesDai-Shi Su, M Kristine Markowitz, Kathy L Murphy, et al.The Journal of Pharmacology and Experimental Therapeutics|March 4, 2008
CYP2C75-involved autoinduction of metabolism in rhesus monkeys of methyl 3-chloro-3'-fluoro-4'-{(1R)-1-[({1-[(trifluoroacetyl)amino]cyclopropyl}carbonyl)amino]ethyl}-1,1'-biphenyl-2-carboxylate (MK-0686), a bradykinin B1 receptor antagonistCuyue Tang, Brian A Carr, Frédéric Poignant, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 19, 2002
Identification of metabolites of a substance P (neurokinin 1 receptor) antagonist in rat hepatocytes and rat plasmaCornelis E C A Hop, Yanfeng Wang, Sanjeev Kumar, et al.Nature Communications|August 1, 2025
Structural convergence and water-mediated substrate mimicry enable broad neuraminidase inhibition by human antibodiesJulia Lederhofer, Andrew J Borst, Lam Nguyen, et al.Immunity|July 28, 2019
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B cell Responses to Influenza HemagglutininSarah F Andrews, Michael J Chambers, Chaim A Schramm, et al.European Journal of Pharmacology|September 15, 2004
Pharmacological characterization and radioligand binding properties of a high-affinity, nonpeptide, bradykinin B1 receptor antagonistRichard W Ransom, Charles M Harrell, Duane R Reiss, et al.Biorxiv : the Preprint Server for Biology|December 16, 2024
Structural Convergence and Water-Mediated Substrate Mimicry Enable Broad Neuraminidase Inhibition by Human AntibodiesJulia Lederhofer, Andrew J Borst, Lam Nguyen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2011
Genotype-guided tamoxifen dosing increases active metabolite exposure in women with reduced CYP2D6 metabolism: a multicenter studyWilliam J Irvin, Christine M Walko, Karen E Weck, et al.Nature Medicine|February 4, 2022
A single residue in influenza virus H2 hemagglutinin enhances the breadth of the B cell response elicited by H2 vaccinationSarah F Andrews, Julie E Raab, Jason Gorman, et al.The Journal of Pharmacology and Experimental Therapeutics|May 27, 2003
A small molecule alpha4beta1/alpha4beta7 antagonist differentiates between the low-affinity states of alpha4beta1 and alpha4beta7: characterization of divalent cation dependenceLinda A Egger, Jin Cao, Christine McCallum, et al.Pageof 6